Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report

    4 hours ago

    As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
    Click here to Read More
    Previous Article
    Noida School Loses CBSE Affiliation Following Complaints Of Harassment, Misconduct
    Next Article
    CBSE Class 10 Science Exam 2026: Physics Toughest? Here's What Teachers Say

    Related India Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment